TANGANELLI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 9.080
EU - Europa 2.483
AS - Asia 1.487
SA - Sud America 17
OC - Oceania 10
AF - Africa 6
Totale 13.083
Nazione #
US - Stati Uniti d'America 9.058
IT - Italia 766
CN - Cina 760
UA - Ucraina 617
DE - Germania 325
TR - Turchia 313
SG - Singapore 309
GB - Regno Unito 287
FI - Finlandia 150
SE - Svezia 144
PL - Polonia 55
HK - Hong Kong 40
FR - Francia 27
CA - Canada 20
AT - Austria 19
BE - Belgio 18
ID - Indonesia 18
NL - Olanda 18
IN - India 13
BR - Brasile 11
AU - Australia 10
IR - Iran 8
LT - Lituania 8
CH - Svizzera 7
JP - Giappone 7
RO - Romania 7
ES - Italia 6
GR - Grecia 5
KR - Corea 5
RU - Federazione Russa 5
VN - Vietnam 5
CL - Cile 4
EG - Egitto 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
BD - Bangladesh 2
BG - Bulgaria 2
IL - Israele 2
MX - Messico 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
DK - Danimarca 1
EE - Estonia 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
TW - Taiwan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 13.083
Città #
Fairfield 1.349
Woodbridge 1.156
Houston 798
Jacksonville 685
Ashburn 613
Chandler 569
Ann Arbor 534
Seattle 504
Cambridge 448
Wilmington 436
Izmir 230
Nanjing 206
Singapore 201
Princeton 147
Beijing 143
San Diego 132
Milan 111
Boardman 101
Ferrara 84
Shenyang 57
Warsaw 53
Addison 45
Nanchang 45
Falls Church 41
Tianjin 41
Los Angeles 39
Hong Kong 38
Jiaxing 38
New York 37
Hebei 35
Santa Clara 35
Bremen 33
Shanghai 33
Redwood City 29
Norwalk 27
Changsha 26
Jinan 26
London 26
Mountain View 25
San Mateo 24
Rome 22
Orange 21
Auburn Hills 20
Vienna 19
Des Moines 18
Brussels 17
Jakarta 17
Kunming 15
Washington 15
Helsinki 14
Ningbo 14
Monmouth Junction 13
Munich 13
Zhengzhou 13
Napoli 12
Lappeenranta 11
Guangzhou 10
Augusta 9
Erzurum 9
Indiana 9
Lanzhou 9
Philadelphia 9
Verona 9
Catanzaro 8
Taizhou 8
Dearborn 7
Leawood 7
Prescot 7
Rende 7
Toronto 7
Chicago 6
Hangzhou 6
Palermo 6
Tappahannock 6
Atella 5
Düsseldorf 5
Frankfurt am Main 5
Minatomirai 5
Torino 5
Acton 4
Catania 4
Claremont 4
Como 4
Cuiabá 4
Donostia-san Sebastián 4
Florence 4
Manchester 4
Yellow Springs 4
Acerra 3
Amsterdam 3
Angri 3
Ardabil 3
Aversa 3
Berlin 3
Cairo 3
Campobasso 3
Chiswick 3
Dong Ket 3
Erlangen 3
Haikou 3
Totale 9.690
Nome #
Trasmissione catecolaminergica 502
Sistemi di trasmissione - trasmissione catecolaminergica. 200
Preclinical studies with modafinil. Evidence for vigilance enhancement and neuroprotection. 198
GET73 prevents ethanol-induced neurotoxicity in primary cultures of rat hippocampal neurons 165
Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia 148
Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia. 147
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 147
Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity 146
Adenosine a2a-d2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: Possible relevance for parkinson’s disease and its treatment 140
Efficient synthesis and biological evaluation of two modafinil analogues 129
Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil. 129
Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission 128
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 127
Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs 125
The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade 124
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices. 122
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 121
Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers 121
6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig 120
Use of superfused synaptosomes to understand the role of receptor–receptor interactions as integrative mechanisms in nerve terminals from selected brain region 120
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 118
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 116
GPCR heteromers and their allosteric receptor-receptor interactions 115
Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation. 114
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]-D-aspartate and endogenous GABA in freely moving guinea-pigs. 113
Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia 113
Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum. 112
Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. 112
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 112
A novel mechanism of cocaine to enhance dopamine D 2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study 112
Changes in gamma-aminobutyric acid release induced by topical administration of drugs affecting its metabolism and receptors: studies in freely moving guinea pigs with epidural cups. 112
Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ9-THC exposure 111
Effect of (-)nicotine on GABA efflux from guinea pig cerebral cortex slices. 109
Understanding the balance and integration of volume and synaptic transmission. Relevance for psychiatry 109
Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease 109
Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study. 109
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 109
Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat 108
Nigral neurotensin receptor regulation of nigral glutamate and nigro-ventral thalamic GABA transmission. A dual probe microdialysis study in intact conscious rat brain. 108
The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor 106
Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study. 106
Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety. 106
Neurotensin as Modulator of Basal Ganglia- Thalamocortical Motor Circuit – Emerging Evidence for Neurotensin NTS1 Receptor as a Potential Target in Parkinson's Disease 106
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 105
Prenatal Exposure to the CB1 Receptor Agonist WIN 55,212-2 Causes Learning Disruption Associated with Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 105
Neurotensin receptors as modulators of glutamatergic transmission. 105
Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens. 105
The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. 104
The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. 104
Neurotensin increases endogenous glutamate release in rat cortical slices. 103
Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms. 103
Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease. 103
Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia. 102
Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat. 102
Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat. 102
Relevance of dopamine D2/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders 102
Inhibitory cholinergic control of endogenous GABA release from electrically stimulated cortical slices and K(+)-depolarized synaptosomes 101
Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders. 101
Adenosine-dopamine interactions in the pathophysiology and treatment of cns disorders 101
null 101
Understanding the Functional Plasticity in Neural Networks of the Basal Ganglia in Cocaine Use Disorder: A Role for Allosteric Receptor-Receptor Interactions in A2A-D2 Heteroreceptor Complexes. 100
Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs. 100
Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats. 99
The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: in vivo and in vitro study 97
Differential Enhancement of Dialysate Serotonin Levels in Distinct Brain Regions of the Awake Rat by Modafinil. Possible Relevance for Wakefulness and Depression. 97
Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks. 97
Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis 97
Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates. 96
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. 96
Intramembrane receptor-receptor interactions: a novel principle in molecular medicine 96
Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release - a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat 96
GET73 increases rat extracellular hippocampal CA1 GABA levels through a possible involvement of local mGlu5 receptor. 95
null 95
Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex. 95
Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. 94
Effects of sarizotan on the corticostriatal glutamate pathways 94
Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides 94
The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. 94
Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by a-glyceryl-phosphorylcholine. 94
Prenatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin produces alterations in cortical neuron development and a long-term dysfunction of glutamate transmission in rat cerebral cortex 93
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. 93
Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine. 93
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis 92
Developmental exposure to methylmercury elicits early cell death in the cerebral cortex and long-term memory deficits in the rat. 91
CONSEGUENZE A BREVE E LUNGO TERMINE INDOTTE DAL CONSUMO DI MARIJUANA DURANTE LA GRAVIDANZA E/O L'ALLATTAMENTO SULLE FUNZIONI COGNITIVE NEUROCHIMICHE E COMPORTAMENTALI DELLA PROLE. 89
Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. 89
The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. 88
null 88
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance. 86
Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors 85
Cortical acetylcholine release is increased and GABA outflow is reduced during morphine withdrawal 84
Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors 84
GET73 modulates rat hippocampal glutamate transmission: Evidence for a functional interaction with mGluR5 84
Nasal administration and brain targeting of an antiischemic agent 82
Receptor pharmacology of the antidyskinetic drug sarizotan 81
Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum. Counteraction by a NTR1-like receptorantagonist. 81
A(2A)/D(2) receptor heteromerization in a model of Parkinson's disease. Focus on striatal aminoacidergic signaling. 80
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 80
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 79
null 78
Totale 11.079
Categoria #
all - tutte 58.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.328
Totale 65.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.924 0 0 0 0 209 339 246 311 247 301 150 121
2020/20211.917 183 165 145 212 101 174 87 240 43 231 232 104
2021/20221.565 57 173 189 76 61 72 94 89 51 113 139 451
2022/20231.443 149 50 48 161 247 209 83 142 218 8 73 55
2023/2024690 71 91 37 18 77 83 27 36 3 9 33 205
2024/2025493 70 62 213 135 13 0 0 0 0 0 0 0
Totale 13.244